|
Market Closed -
Nasdaq
16:00:00 2026-08-27 EDT
|
5-day change | 1st Jan Change | ||
| 59.37 USD | +0.24% |
|
-0.74% | +13.22% |
| 08-04 | Crispr Therapeutics Posts "Quiet" Quarter as Casgevy Advances, SiRNA Data Readouts Near, RBC Says | MT |
| 08-04 | Swiss stocks - Factors to watch on August 4 | RE |
| Market Cap | 5.73B 4.92B 4.6B 4.21B 7.94B 547B 7.96B 54.5B 21.31B 276B 21.5B 21.04B 912B | P/E 2026 * |
-13.6x | P/E 2027 * | -18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4.28B 3.67B 3.44B 3.15B 5.93B 409B 5.95B 40.74B 15.93B 206B 16.07B 15.73B 682B | EV / Sales 2026 * |
105x | EV / Sales 2027 * | 30.3x |
| Free-Float |
94.01% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : CRISPR Therapeutics AG
| 1 day | +0.35% | ||
| 1 week | -0.74% | ||
| Current month | +23.71% | ||
| 1 month | +27.57% | ||
| 3 months | +15.08% | ||
| 6 months | -3.84% | ||
| Current year | +13.22% |
| 1 week | 56.62 |  | 62.54 |
| 1 month | 45.89 | | 62.54 |
| Current year | 44.12 | | 63.45 |
| 1 year | 44.12 | | 78.48 |
| 3 years | 30.04 | | 91.1 |
| 5 years | 30.04 | | 129.5 |
| 10 years | 11.63 | | 220.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samarth Kulkarni
CEO | Chief Executive Officer | 47 | 2017-11-30 |
Raju Prasad
DFI | Director of Finance/CFO | 42 | 2023-03-13 |
Naimish Patel
CTO | Chief Tech/Sci/R&D Officer | - | 2024-05-27 |
| Director | Title | Age | Since |
|---|---|---|---|
Simeon George
BRD | Director/Board Member | 49 | 2015-04-28 |
Ali Behbahani
BRD | Director/Board Member | 49 | 2015-03-31 |
Samarth Kulkarni
CHM | Chairman | 47 | 2023-09-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/7/26 | Don | Chief Financial Officer | -750 | 0.0008% | ||
| 6/5/26 | GSK Equity Investments Ltd.
| Free | Company | 13,000 | 0.0135% | |
| 2/18/26 | Fiscal year | General Counsel | 9,762 | 0.0102% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.24% | -0.74% | +8.18% | +19.48% | 5.73B | |
| +0.10% | +1.59% | +1.76% | +24.32% | 50.96B | |
| +2.65% | +3.02% | +493.29% | +567.32% | 46.18B | |
| -0.88% | -1.16% | +20.58% | +87.74% | 42.73B | |
| +0.33% | +5.26% | +39.74% | +19.80% | 43.04B | |
| -2.27% | -3.02% | +14.22% | +51.50% | 33.48B | |
| -1.21% | +0.54% | +30.32% | +135.38% | 17.28B | |
| -0.36% | -3.95% | - | - | 16.43B | |
| +0.25% | +3.31% | +11.38% | +30.68% | 14.73B | |
| +0.44% | +2.21% | +81.06% | +47.92% | 14.09B | |
| Average | +0.09% | +1.10% | +77.84% | +109.35% | 28.46B | |
| Weighted average by Cap. | +0.30% | +1.12% | +103.71% | +139.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 40.83M 35.05M 32.81M 30.05M 56.6M 3.9B 56.76M 389M 152M 1.97B 153M 150M 6.5B | 157M 134M 126M 115M 217M 14.95B 218M 1.49B 582M 7.54B 588M 575M 24.94B |
| Net income | -432M -371M -348M -318M -599M -41.3B -601M -4.11B -1.61B -20.81B -1.62B -1.59B -68.89B | -351M -302M -282M -259M -487M -33.57B -489M -3.34B -1.31B -16.92B -1.32B -1.29B -55.99B |
| Net Debt | -1.45B -1.24B -1.16B -1.06B -2B -138B -2.01B -13.76B -5.38B -69.61B -5.43B -5.31B -230B | -980M -841M -787M -721M -1.36B -93.58B -1.36B -9.32B -3.64B -47.16B -3.68B -3.6B -156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-27 | US$59.37 | +0.24% | 1,185,944 |
| 26-08-26 | US$59.23 | -2.74% | 959,931 |
| 26-08-25 | US$60.90 | +6.70% | 2,083,671 |
| 26-08-24 | US$57.08 | -4.08% | 1,119,658 |
| 26-08-21 | US$59.50 | +2.37% | 2,453,841 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CRSP Stock
Select your edition
All financial news and data tailored to specific country editions
